Recombinant human thyroid stimulating hormone-aided 131I treatment for differentiated thyroid carcinoma
10.3760/cma.j.issn.1674-6090.2016.01.005
- VernacularTitle:重组人促甲状腺激素在131I治疗分化型甲状腺癌中的应用研究
- Author:
Zhongjing WANG
;
Xuyan ZHANG
;
Diyu LU
;
Minxian SUN
;
Zihui XU
;
Sheng DING
- Publication Type:Journal Article
- Keywords:
Recombinant human thyroid stimulating hormone;
131I;
Differentiated thyroid carcinoma
- From:
Chinese Journal of Endocrine Surgery
2016;10(1):19-22
- CountryChina
- Language:Chinese
-
Abstract:
Objective To observe the infiuence of recombinant human thyroid stimulating hormone(rhTSH)-aided 131I treatment for patients with differentiated thyroid carcinoma (DTC)and its efficacy on thyroid hormone level.Methods 20 cases with DTC admitted from Nov.2010 to Jun.2014 were divided into 2 groups.11 cases received rhTSH-aided 131I treatment (rhTSH-aided group)and the other 9 cases received 131I treatment after thyroid hormone withdrawal (THs withdrawal group).The influence of the 2 treatment methods on the serum TSH,FT3,FT4,Tg was evaluated,and the therapeutic effects were assessed according to 131I whole body scintigraphy (WBS)and Tg-negative rate.Results The serum TSH was significantly higher in rhTSH-aided group than that before treatment(t=27.70,P＜ 0.001)and in THs withdrawal group (t=7.18,P＜0.001).TSH levels of all patients were＞30 mU/L.WBS displayed that the thyroid remnant clearance rate was 72.73％(8 cases)nd 66.67％(6 cases)respectively in rhTSH-aided group and THs with-drawal group and there was no statistical difference between the 2 groups(x2=0.178,0.673).Conclusion The rhTsH treatment can help to accomplish the preparation of 131I treatment for DTC and acquire satisfactory ablation efficacy.
